Blumberg Dana M

Sohail Marium, Hirji Sitara H, Liebmann Jeffrey M, Glass Lora D, Blumberg Dana M

A free home contrast sensitivity test correlated with glaucomatous macular damage (10-2 VF), suggesting its potential for remote glaucoma monitoring.

Chang Angela Y, Tsamis Emmanouil, Blumberg Dana M, Al-Aswad Lama A, Cioffi George A, Hood Donald C et al.

Macular OCT and visual field parameters better reflect IOP-related glaucoma progression than conventional measures. Systemic hypertension was not linked to progression in this study, highlighting macular metrics as sensitive endpoints.

Liebmann Jeffrey M, Hood Donald C, de Moraes Carlos Gustavo, Blumberg Dana M, Harizman Noga, Kresch Yocheved S et al.

Researchers developed an OCT-based method to detect glaucoma without perimetry, offering a potential new diagnostic tool for clinical practice and research, pending further validation.

De Moraes Carlos Gustavo, John Simon W M, Williams Pete A, Blumberg Dana M, Cioffi George A, Liebmann Jeffrey M

This study found nicotinamide and pyruvate improved visual function in glaucoma patients, suggesting these supplements may offer neuroprotection and warrant further long-term investigation to slow progression.

Yu Sarah N, Hood Donald C, Blumberg Dana M, Chang Stanley, Greenstein Vivienne C

This study found that careful pre-operative comparison of visual fields and OCT scans helps guide macular surgery and evaluate outcomes in glaucoma patients.

Khan Sabine S, Hirji Sitara H, Hood Donald C, Liebmann Jeffrey M, Blumberg Dana M

This study investigated if macular nerve damage in glaucoma affects facial recognition, finding a potential link between structural damage and this visual function.

Sun Ashley, Tsamis Emmanouil, Eguia Melvi D, Liebmann Jeffrey M, Blumberg Dana M, Al-Aswad Lama A et al.

This study found global OCT metrics for glaucoma progression have high false positive/negative rates due to scanning errors and missing local damage, questioning their clinical utility.

Hirji Sitara H, Hood Donald C, Liebmann Jeffrey M, Blumberg Dana M

This study found diffuse, not focal, glaucomatous macular damage significantly impairs contrast sensitivity and facial recognition. Identifying diffuse damage via OCT/VF can help minimize visual disability.

Shukla Aakriti G, Sirinek Portia E, De Moraes C Gustavo, Blumberg Dana M, Cioffi George A, Skaat Alon et al.

Disc hemorrhages in glaucoma are linked to more severe central visual field damage and faster progression, emphasizing the need for intensive central VF monitoring.

Chu Chia-Kai, Liebmann Jeffrey M, Cioffi George A, Blumberg Dana M, Al-Aswad Lama A

This study found early reoperation rates for glaucoma surgery complications were low (2.4%), mainly for bleb leaks or tube issues, indicating overall safety but highlighting specific risks.

Hirji Sitara H, Liebmann Jeffrey M, Hood Donald C, Cioffi George A, Blumberg Dana M

Glaucoma patients with macular damage show impaired facial recognition, even with good central acuity, partly due to reduced contrast sensitivity. This highlights a critical functional impact beyond vision loss.

De Moraes Carlos Gustavo, Paula Jayter Silva, Blumberg Dana M, Cioffi George A, Al-Aswad Lama A, Girkin Christopher A et al.

A new algorithm for 10-2 visual fields accurately detects glaucoma progression, identifying eyes with faster macular damage. This tool can guide clinical management of central vision loss.

Hood Donald C, Tsamis Emmanouil, Bommakanti Nikhil K, Joiner Devon B, Al-Aswad Lama A, Blumberg Dana M et al.

This study found excellent structure-function agreement in early glaucoma using automated OCT and both 24-2/10-2 visual fields, suggesting damage correlation is better than commonly perceived for diagnosis and monitoring.

Blumberg Dana M, Liebmann Jeffrey M, Hirji Sitara H, Hood Donald C

This study found diffuse macular damage in mild-moderate glaucoma predicts worse low-light vision and mobility, highlighting its impact on daily function beyond standard tests.

Yang Xiangjun, Zeng Qun, Göktas Emre, Gopal Kalashree, Al-Aswad Lama, Blumberg Dana M et al.

Glaucoma patients showed fewer regulatory T cells and increased pro-inflammatory T-cell activity, suggesting impaired immune suppression which could contribute to neurodegeneration or serve as a biomarker.

De Moraes Carlos Gustavo, Sun Ashley, Jarukasetphon Ravivarn, Rajshekhar Rashmi, Shi Lynn, Blumberg Dana M et al.

This study found current glaucoma staging systems, based on 24-2 visual fields, often miss significant macular damage in glaucoma patients, underestimating disease severity and highlighting the need for improved staging with macular-focused tests.

Blumberg Dana M

Garg Aakriti, Hood Donald C, Pensec Noelle, Liebmann Jeffrey M, Blumberg Dana M

Early macular damage in glaucoma, identified by structural and functional tests, significantly reduces vision-related quality of life, even in early stages. This highlights the macula's critical role in patient well-being.

Muhammad Hassan, Fuchs Thomas J, De Cuir Nicole, De Moraes Carlos G, Blumberg Dana M, Liebmann Jeffrey M et al.

A hybrid deep learning method using single wide-field OCT scans accurately distinguished early glaucoma from healthy suspects (93.1% accuracy), outperforming standard clinical metrics and showing promise for screening.

Hondur Gözde, Göktas Emre, Yang Xiangjun, Al-Aswad Lama, Auran James D, Blumberg Dana M et al.

This study found elevated oxidative stress markers (protein carbonyls, AGEs) in glaucoma patients' blood and aqueous humor, suggesting their potential as clinical biomarkers for early diagnosis and monitoring.

Blumberg Dana M, De Moraes Carlos Gustavo, Prager Alisa J, Yu Qi, Al-Aswad Lama, Cioffi George A et al.

This study found that central 10-2 visual field damage, often missed by 24-2 tests, strongly impacts glaucoma patients' quality of life, highlighting its clinical importance for comprehensive assessment.

Prager Alisa J, Hood Donald C, Liebmann Jeffrey M, De Moraes C Gustavo, Al-Aswad Lama A, Yu Qi et al.

This study found that diffuse macular damage in glaucoma patients, identified by OCT, is a stronger predictor of worse vision-related quality of life than simple thickness measurements, guiding personalized care.

De Moraes C Gustavo, Murphy James T, Kaplan Chad M, Reimann Jeremy J, Skaat Alon, Blumberg Dana M et al.

This study found that baseline βPPA was linked to faster visual field progression in European descent glaucoma patients, but not African descent. βPPA progression itself didn't predict faster visual field loss.

Garg Aakriti, Blumberg Dana M, Al-Aswad Lama A, Oll Maris, Yzer Suzanne, Forbes Max et al.

This study found RPD in early AMD are linked to β-PPA, but choroidal thickness confounds this. Understanding this shared pathway may inform glaucoma and AMD therapies.

Blumberg Dana M, De Moraes Carlos Gustavo, Liebmann Jeffrey M, Garg Reena, Chen Cynthia, Theventhiran Alex et al.

SD-OCT alone showed superior agreement and diagnostic accuracy compared to visual fields and photos for identifying early glaucoma in suspects, highlighting its clinical utility.